- Carbon Markets 101: Designing Projects That Deliver Real Climate Impact
- The Next Phase of Financial Inclusion in Africa: Digital Identity, Trust and Collaboration
- A Market Awakens: Kenya’s Capital Markets Regain Momentum into 2026
- Global: Few economic impacts from Iran conflict outside the GCC
- Kenya: Capital markets licensing regime overhauled – What market participants need to know?
French Drugs Maker Targets Africa With Nigerian Acquisition
LAGOS (Capital Markets in Africa) – Biogaran SAS, a closely held French pharmaceuticals manufacturer, plans to tap into Nigeria’s $1.3 billion drugs market as a launchpad for its expansion into Africa, company President Pascal Briere said. The unit of France’s second-largest drug maker, Les Laboratoires Servier, last month acquired Nigeria’s Swipha Limited. after an initial $500,000 investment. Biogaran expects Nigeria’s pharmaceuticals industry to grow by more than 12 percent annually. “We found that Nigeria is well adapted for what we…
Read More


